Literature DB >> 3010752

Fatal outcome in Japanese encephalitis.

D S Burke, W Lorsomrudee, C J Leake, C H Hoke, A Nisalak, V Chongswasdi, T Laorakpongse.   

Abstract

Forty-nine consecutive patients with laboratory-confirmed acute Japanese encephalitis were studied to identify risk factors present at hospital admission which were associated with a fatal outcome. Sixteen patients (33%) died. The following constellation of findings correlated with a fatal outcome: infectious virus in cerebrospinal fluid (CSF), low levels of Japanese encephalitis virus-specific IgG and IgM in both CSF and serum, and a severely depressed sensorium. Age, sex, days ill before admission, distance from home to the hospital, past medical history, CSF protein content, and CSF leukocyte count were not significant risk factors. Among patients hospitalized for acute Japanese encephalitis, a vigorous virus-specific immunoglobulin response, both systemically and locally within the central nervous system, is a good marker for survival, and may be an inherently important factor in recovery from illness.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3010752     DOI: 10.4269/ajtmh.1985.34.1203

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  26 in total

1.  Serum and cerebrospinal fluid immunoglobulins M, A, and G in Japanese encephalitis.

Authors:  X Y Han; Q W Ren; Z Y Xu; T F Tsai
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

2.  Germ Line IgM Is Sufficient, but Not Required, for Antibody-Mediated Alphavirus Clearance from the Central Nervous System.

Authors:  Voraphoj Nilaratanakul; Jie Chen; Oanh Tran; Victoria K Baxter; Elizabeth M Troisi; Jane X Yeh; Diane E Griffin
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

Review 3.  Arboviruses and the central nervous system.

Authors:  D E Griffin
Journal:  Springer Semin Immunopathol       Date:  1995

4.  Specificity of immunoglobulin M and G antibody responses in humans infected with eastern and western equine encephalitis viruses: application to rapid serodiagnosis.

Authors:  C H Calisher; V P Berardi; D J Muth; E E Buff
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

5.  Pivotal role of antibody and subsidiary contribution of CD8+ T cells to recovery from infection in a murine model of Japanese encephalitis.

Authors:  Maximilian Larena; Matthias Regner; Eva Lee; Mario Lobigs
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

6.  Neutrophil chemotactic factor produced by Japanese encephalitis virus stimulated macrophages.

Authors:  N Khanna; M Agnihotri; A Mathur; U C Chaturvedi
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

7.  A cohort study to assess the new WHO Japanese encephalitis surveillance standards.

Authors:  Tom Solomon; Thi Thu Thao; Penny Lewthwaite; Mong How Ooi; Rachel Kneen; Nguyen Minh Dung; Nicholas White
Journal:  Bull World Health Organ       Date:  2008-03       Impact factor: 9.408

8.  Alteration in plasma glucose levels in Japanese encephalitis patients.

Authors:  Apurva Tandon; Aditi Singh; Ekta Atrishi; S K Saxena; Asha Mathur
Journal:  Int J Exp Pathol       Date:  2002-02       Impact factor: 1.925

9.  Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance.

Authors:  Susan Hills; Alya Dabbagh; Julie Jacobson; Anthony Marfin; David Featherstone; Joachim Hombach; Pem Namgyal; Manju Rani; Tom Solomon
Journal:  BMC Infect Dis       Date:  2009-12-29       Impact factor: 3.090

10.  Japanese encephalitis-a pathological and clinical perspective.

Authors:  Debapriya Ghosh; Anirban Basu
Journal:  PLoS Negl Trop Dis       Date:  2009-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.